GlassScriptPhysician profile
Michael A Wilmink
NPI 1215921523
$347,426.18
in general payments reported to CMS, 2019-2025
16 companies · $21K in 2025
The $21K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71K · 2020: $87K · 2021: $44K · 2022: $52K · 2023: $48K · 2024: $24K · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $91K · Food and Beverage: $1,570 · Travel and Lodging: $473 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $90,989.68 |
| Food and Beverage | $1,569.67 |
| Travel and Lodging | $473.40 |
| Education | $169.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nextstep Arthropedix, LLC | $343,876.31 | 2019-2025 | Insitu Hip System |
| Smith+Nephew, INC. | $848.51 | 2020-2025 | Journey II, Redapt, Real Intelligence |
| Stryker Corporation | $739.44 | 2020-2025 | Mako, Insignia |
| Conformis, INC. | $626.24 | 2021 | |
| Medacta USA, INC. | $245.53 | 2020-2021 | |
| Orthofix Medical, INC. | $204.77 | 2019-2025 | Physio-Stim, Accelstim |
| Fidia Pharma USA INC. | $181.66 | 2025 | Hymovis, Richplat Ortho Prp System |
| Medtronic, INC. | $155.02 | 2025 | Unid_pass, Plasmablade(Tm) |
| Illuminoss Medical, INC. | $127.25 | 2025 | Photodynamic Bone Stabilization Procedure Pack |
| Pacira Pharmaceuticals Incorporated | $123.19 | 2023 | Iovera |
| Maxx Orthopedics, INC. | $95.96 | 2024 | |
| Uoc USA INC | $77.57 | 2025 | U2 Pf+, Psi |
| Depuy Synthes Sales INC. | $40.86 | 2023 | Truespan Orthocord |
| Vericel Corporation | $40.69 | 2024 | Maci |
| Si-Bone, INC. | $27.98 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.20 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wilmink listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.